Identification of ferroptosis hub gene cDKN1A relating to immune microenvironment in rheumatoid arthritis via bioinformatic analysis and experimental verification - Summary - MDSpire
Advertisement
Identification of ferroptosis hub gene cDKN1A relating to immune microenvironment in rheumatoid arthritis via bioinformatic analysis and experimental verification
To investigate the role of ferroptosis in rheumatoid arthritis (RA) and identify ferroptosis-related biomarkers associated with RA through bioinformatics and experimental validation using microarray datasets.
Approach:
Data Acquisition: Utilized two RA microarray datasets from Gene Expression Omnibus (GEO) for differential expression analysis between RA and healthy controls.
Differential Expression Analysis: Performed using the 'limma' package with a dual-threshold strategy to identify differentially expressed genes (DEGs) related to ferroptosis.
Machine Learning: Applied random forest and SVM recursive feature elimination to identify key ferroptosis-related DEGs.
Correlation Analysis: Conducted correlation analysis between identified biomarkers and infiltrating immune cells.
Experimental Validation: Performed in vitro experiments to clarify the regulatory relationship of key biomarkers with ferroptosis in synovial cells.
Key Findings:
Identification of ferroptosis-related hub gene cDKN1A associated with RA.
Differential expression of ferroptosis-related genes between RA and healthy controls.
Correlation of identified biomarkers with immune cell infiltration.
Interpretation:
The study investigates the involvement of ferroptosis in RA and identifies potential biomarkers for further research.
Limitations:
The study relies on bioinformatics analysis, which may not capture all biological complexities, and the findings may not be generalizable beyond the studied datasets.
Experimental validation may be limited to specific cell types and conditions, potentially affecting the applicability of the results.
Conclusion:
The findings indicate a role of ferroptosis in RA, with cDKN1A identified as a potential biomarker, warranting further investigation.
